Strongyloidiasis Diagnosed by ELISA in Brussels: A Bicentric Retrospective Study
Microorganisms · 12.08.2026 · 14 (8) · 1781
DOI: 10.3390/microorganisms14081781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 12.08.2026. Verfasst von Juliette Becu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Infectious Diseases, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite a significant population of migrants from endemic countries and of Europeans traveling to these regions, no Belgian study and few European studies have reported on strongyloidiasis. This retrospective study, conducted between January 2012 and December 2021, aimed to compare demographic data, clinical characteristics and management appropriateness of adult patients from Hôpital Universitaire de Bruxelles-Erasme and Centre Hospitalier Universitaire Saint-Pierre who had a positive serology for Strongyloides stercoralis. Serology results were classified as weakly positive (WP) or positive (P), and the two groups were compared. Qualitative and continuous data were expressed as numbers and medians, respectively, and compared using Fisher’s exact or Wilcoxon–Mann–Whitney tests, with a p-value < 0.05 considered statistically significant. A total of 358 patients (50% females) were included, with a median age of 52 (IQR: 40–63): 225 (62.8%) had WP and 133 (37.2%) had P results. Overall, 217/358 (60.6%) of the patients had at least one comorbidity, and 52/358 (14.5%) had an immunosuppressive factor. In total, 120/358 (33.5%) were symptomatic and 160/352 (45.5%) had blood eosinophilia. Only 51/358 (14.2%) benefitted from appropriate clinical management. Severe complications occurred in 17/358 (4.7%) patients, with two deaths (0.6%). This first Belgian study about strongyloidiasis shows that, despite low rates of severe complications and mortality, significant treatment delays were observed, requiring future improvement and monitoring.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic of Infectious Diseases, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.
- Department of Infectious Diseases, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium.
- Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), 1000 Brussels, Belgium.
- Faculty of Medicine and Pharmacy, University of Mons (UMONS), 7000 Mons, Belgium.
- Laboratory of Parasitology, Faculty of Medicine, ULB Center for Research in Immunology (UCRI), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium.
ORCID-Profile: Juliette Becu, Charlotte Martin, Sigi Van den Wijngaert, Delphine Martiny
Zitieren
APA
Becu, J., Martin, C., Van den Wijngaert, S., Martiny, D., Truyens, C., & Hites, M. (2026). Strongyloidiasis Diagnosed by ELISA in Brussels: A Bicentric Retrospective Study. Microorganisms, 14(8), 1781. https://doi.org/10.3390/microorganisms14081781
Vancouver
Becu J, Martin C, Van den Wijngaert S, Martiny D, Truyens C, Hites M. Strongyloidiasis Diagnosed by ELISA in Brussels: A Bicentric Retrospective Study. Microorganisms. 2026;14(8):1781. doi:10.3390/microorganisms14081781
BibTeX
@article{Becu2026,
author = {Becu, Juliette and Martin, Charlotte and Van den Wijngaert, Sigi and Martiny, Delphine and Truyens, Carine and Hites, Maya},
title = {Strongyloidiasis Diagnosed by ELISA in Brussels: A Bicentric Retrospective Study},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {8},
pages = {1781},
doi = {10.3390/microorganisms14081781}
}
EUVIMED